Friday, July 18, 2014

This Week in Sickle Cell News

Hello All!

For patients with SCD, anesthetic techniques, anesthetic agents and surgical trauma pose additional risk. Perioperative care for SCD patients hence has to take into account their needs. This is the subject of a case report out of the Mustafa Kemal University Faculty of Medicine, Hatay, Turkey :
Perioperative Anaesthetic Approach in a Homozygous Sickle Cell Anaemia Patient with Frequent Pain Crises.

This week also saw the publication of important theoretical foundations for stem cell-based gene therapy, from  scientists at the Salk Institute of Biological Studies. According to a Science Daily report, the safety and reliability of existing targeted gene correction technologies were evaluated, and a new method was developed. This has important implications for attempts to model human diseases and develop potential cell replacement therapy. See the Science Daily report here. Read the research paper here.

Other findings this week:

Effects of 5‐hydroxymethyl‐2‐furfural on the volume and membrane permeability of red blood cells from patients with sickle cell disease.

Prenatal Diagnosis of Sickle Cell Disease by PCR

Clinical Significance of Assessment of Thrombospondin and Placenta Growth Factor Levels in Patients with Sickle Cell Anemia: Two Centers Egyptian Studies

β-Thalassemia hijacking ineffective erythropoietin and iron overload: Two case reports and a review of literature


Have a great weekend!


The ASN Team

No comments:

Post a Comment